The downstream result for patients is improved metabolic flexibility: the body becomes better at switching between fuel sources rather than defaulting to fat storage
While other peptides may address specific aspects of fat loss, 5-Amino-1MQs targeted action on NNMT offers a novel and promising approach to improving metabolic health
GLP-1 agonists commonly cause nausea, vomiting, diarrhea, and abdominal painsymptoms that overlap with Crohn's disease
These results suggest that GCLC may serve as a promising biomarker for early diagnosis and a potential therapeutic target in PD
MOTS-c is a 16-amino acid peptide encoded within the mitochondrial 12S rRNA gene
Muff, R., Buhlmann, N., Fischer, J